Login
Compartmentalisation of death receptor signalling in cancer
Oncogenesis, Published online: 31 August 2026; doi:10.1038/s41389-026-00654-w
Compartmentalisation of death receptor signalling in cancer
Reading view
NKCC1 as a regulator of stemness and redox balance in colorectal cancer
Oncogenesis, Published online: 31 August 2026; doi:10.1038/s41389-026-00651-z
NKCC1 as a regulator of stemness and redox balance in colorectal cancer
Stanniocalcin 1 contributes to glioma stem cells phenotypic plasticity through NOTCH1/STAT3/GFPT2 axis
Oncogenesis, Published online: 29 August 2026; doi:10.1038/s41389-026-00653-x
Stanniocalcin 1 contributes to glioma stem cells phenotypic plasticity through NOTCH1/STAT3/GFPT2 axis
CD44v5 promotes triple-negative breast cancer cisplatin resistance by enhancing IL-4/IL-4Rα/STAT3 pathway and stabilizing membranous SLC7A11
Oncogenesis, Published online: 21 August 2026; doi:10.1038/s41389-026-00650-0
CD44v5 promotes triple-negative breast cancer cisplatin resistance by enhancing IL-4/IL-4Rα/STAT3 pathway and stabilizing membranous SLC7A11
A novel combinatorial treatment for Neurofibromatosis type 1 tumours revealed through cross-species genetic analysis
Oncogenesis, Published online: 21 August 2026; doi:10.1038/s41389-026-00643-z
A novel combinatorial treatment for Neurofibromatosis type 1 tumours revealed through cross-species genetic analysis
Dual downregulation of HRK and BAD promotes BCL-xL-mediated docetaxel resistance in prostate cancer
Oncogenesis, Published online: 20 August 2026; doi:10.1038/s41389-026-00652-y
Dual downregulation of HRK and BAD promotes BCL-xL-mediated docetaxel resistance in prostate cancer
The role of m<sup>6</sup>A reader YTHDF2 in lymphangiogenesis via RNF43/WNT5B in oral squamous cell carcinoma
Oncogenesis, Published online: 20 August 2026; doi:10.1038/s41389-026-00648-8
The role of m6A reader YTHDF2 in lymphangiogenesis via RNF43/WNT5B in oral squamous cell carcinoma
Disruption of the AR/ZNF217/PROM2 axis sensitizes prostate cancer to ferroptosis and enzalutamide therapy
Oncogenesis, Published online: 11 August 2026; doi:10.1038/s41389-026-00649-7
Disruption of the AR/ZNF217/PROM2 axis sensitizes prostate cancer to ferroptosis and enzalutamide therapy